These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2316298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Histomorphologic prognostic factors in stage I endometrial cancers].
    Köhler U, Bilek K, Rosenkranz M.
    Zentralbl Gynakol; 1987; 109(20):1245-54. PubMed ID: 3425025
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Management of endometrial adenocarcinoma stage I with surgical staging followed by tailored adjuvant radiation therapy.
    DiSaia PJ, Creasman WT.
    Clin Obstet Gynaecol; 1986 Dec; 13(4):751-65. PubMed ID: 3791829
    [No Abstract] [Full Text] [Related]

  • 9. The significance of the pathologic findings in endometrial cancer.
    Christopherson WM.
    Clin Obstet Gynaecol; 1986 Dec; 13(4):673-93. PubMed ID: 3024898
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB.
    Cancer; 1997 Oct 01; 80(7):1234-40. PubMed ID: 9317173
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
    Eloubeidi MA, Desmond R, Arguedas MR, Reed CE, Wilcox CM.
    Cancer; 2002 Oct 01; 95(7):1434-43. PubMed ID: 12237911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.